Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ryan W Johnson"'
Autor:
Ryan W Johnson, Kay W P Ng, Alexander R Dietz, Mary E Hartman, Jack D Baty, Nausheen Hasan, Craig M Zaidman, Michael Shoykhet
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0207720 (2018)
IMPORTANCE:ICU-acquired muscle atrophy occurs commonly and worsens outcomes in adults. The incidence and severity of muscle atrophy in critically ill children are poorly characterized. OBJECTIVE:To determine incidence, severity and risk factors for m
Externí odkaz:
https://doaj.org/article/a1c12ae16db14c6382b328f15e4d50dc
Autor:
Amy L. Baxter, Kyle R. Schwartz, Ryan W. Johnson, Ann-Marie Kuchinski, Kevin M. Swartout, Arni S. R. Srinivasa Rao, Robert W. Gibson, Erica Cherian, Taylor Giller, Houlton Boomer, Matthew Lyon, Richard Schwartz
ImportanceSARS-CoV-2 enters the nasopharynx to replicate; nasal irrigation soon after diagnosis could reduce viral load and inhibit furin cleavage necessary for cell entry, thereby reducing morbidity and mortality.ObjectiveTo determine whether initia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48c78378fa095215a51fbd87333df088
https://doi.org/10.1101/2021.08.16.21262044
https://doi.org/10.1101/2021.08.16.21262044
Autor:
Amy L Baxter, Kyle R Schwartz, Ryan W Johnson, Ann-Marie Kuchinski, Kevin M Swartout, Arni S R Srinivasa Rao, Robert W Gibson, Erica Cherian, Taylor Giller, Houlton Boomer, Matthew Lyon, Richard Schwartz
Publikováno v:
Ear, Nose & Throat Journal. :014556132211237
Objective To determine whether initiating saline nasal irrigation after COVID-19 diagnosis reduces hospitalization and death in high-risk outpatients compared with observational controls, and if irrigant composition impacts severity. Methods Particip
Autor:
Danielle A. Griffin, Kristin N. Heller, Ellyn Peterson, Hillarie P. Windish, Kimmo Lehtimäki, Jerry R. Mendell, Louise R. Rodino-Klapac, Ryan W. Johnson, Rachael A. Potter, Plavi Mittal, Douglas E. Albrecht, Patricia C. Sondergaard, Eric R. Pozsgai
Publikováno v:
Human Gene Therapy
Dysferlinopathies comprise a family of disorders caused by mutations in the dysferlin (DYSF) gene, leading to a progressive dystrophy characterized by chronic muscle fiber loss, fat replacement, and fibrosis. To correct the underlying histopathology
Publikováno v:
Mech Dev
Paired box (Pax) proteins function as regulators of coordinated development in organogenesis by controlling factors such as cell growth and differentiation necessary to organize multiple cell types into a single, cohesive organ. Previous work has sug
Autor:
Danielle A. Griffin, Kristin N. Heller, Zarife Sahenk, W. David Arnold, William E. Grose, Jarred M. Whitlock, Ryan W. Johnson, Eric R. Pozsgai, H. Criss Hartzell, Louise R. Rodino-Klapac
Publikováno v:
Human Molecular Genetics. 25:1900-1911
Limb-girdle muscular dystrophies are a genetically diverse group of diseases characterized by chronic muscle wasting and weakness. Recessive mutations in ANO5 (TMEM16E) have been directly linked to several clinical phenotypes including limb-girdle mu
Publikováno v:
Vaccine. 29:1211-1221
The pneumococcal polysaccharide conjugate vaccine which includes a nonacylated protein D carrier from Haemophilus influenzae has been recently licensed for use in many countries. While this vaccine is protective against nontypeable Haemophilus influe
Autor:
Ryan W. Johnson, Helen M. Chamberlin
Publikováno v:
Mechanisms of Development. 125(5-6):486-497
The Pax-6 gene encodes a transcription factor essential for the development of eyes and other sensory organs in species ranging from planaria to mice. Because Pax-6 activity can be both necessary and sufficient for eye organogenesis, much work has fo
Autor:
Danielle A. Griffin, William E. Grose, Patricia C. Sondergaard, Chrystal L. Montgomery, Louise R. Rodino-Klapac, Ryan W Johnson, Jerry R. Mendell, Zarife Sahenk, Eric R. Pozsgai, Kelly Reed Clark, Kristin Heller, Joseph Liu, Kim Shontz
Publikováno v:
Annals of Clinical and Translational Neurology
Objective Dysferlinopathies are a family of untreatable muscle disorders caused by mutations in the dysferlin gene. Lack of dysferlin protein results in progressive dystrophy with chronic muscle fiber loss, inflammation, fat replacement, and fibrosis
Autor:
Patricia C. Sondergaard, Louise R. Rodino-Klapac, Jerry R. Mendell, Eric Pozsgai, Danielle A. Griffin, Ryan W Johnson
Publikováno v:
Neuromuscular Disorders. 24:851-852
There is no cure for dysferlinopathies, a group of related disorders caused by absent or mutant dysferlin (DYSF). Lack of dysferlin leads to progressive dystrophy with chronic muscle fiber loss, inflammation, fat replacement and fibrosis leading to d